证券研究报告|公司深度研究报告 [Table_Date] 2026 年 2 月 4 日 [Table_Title] 布局省际游轮业务，迎接成长新纪元 [Table_Title2] 三峡旅游(002627) [Table_Summary] ► 三峡游轮：立足"两峡一坝"旅游产品体系，省际 游轮项目即将落地 三峡旅游是宜昌市旅游行业头部企业，过往业务重心包括乘 用车经销及服务业务、旅游综合服务、供应链管理业务三 块，23 年 12 月通过出售股权形式剥离资金密集型的乘用车 经销及服务业务、供应链管理业务后，旅游综合业务成为主 业，观光游轮成为收入/毛利主要支撑点。观光游轮业务主 要基于"两峡一坝"运营一日游旅游产品，包括"长江夜 游"、"升船机"、"高峡平湖"等匹配多层次观光游览需求的 产品体系，根据 25 年半年报，截至 25H1 末公司旗下游船数 量已达 32 艘，其中两坝一峡豪华观光游轮 6 艘、其他游船 24 艘、在建省际豪华游轮 2 艘，24 年观光游轮业务贡献收 入 2.06 亿元/同比+17.73%，较 19 年同期+135.01%。 ► 银发群体需求匹配：省际游轮产品有效解决中老年 客群出行痛点， ...

证券研究报告|宏观点评报告 [Table_Date] 2026 年 02 月 03 日 [Table_Title] 资产配置日报：绝地反击 2 月 3 日，随着市场逐渐消化美联储换帅的潜在影响，近期超跌资产普遍进入修复状态。伦敦金现货单日涨 幅超 5%，重新站上 4900 美元/盎司，伦敦银现货涨幅则超过 9%，价格回升至 86 美元/盎司之上；亚太地区主流 指数迎来普涨，日经 225、韩国综指涨幅达到 3.92%、6.84%；国内股指同样重振旗鼓，沪深 300、中证 2000、 科创综指分别上涨 1.18%、2.83%、2.44%。 权益市场缩量反弹。万得全 A上涨 2.12%，全天成交额 2.57万亿元，较昨日（2月 2日）缩量 410亿元。港 股方面，恒生指数上涨 0.22%，恒生科技下跌 1.07%。南向资金净流入 9.52 亿港元，其中腾讯控股净流入 19.55 亿港元，中芯国际和阿里巴巴则分别净流出 15.77 亿港元和 11.98 亿港元。 大跌之后，个股普遍反弹，题材行情接力低位修复逻辑。地产和白酒在开盘后表现活跃，两者均为 1 月 29 日 低位反弹的代表性品种，指向开盘时部分资金仍尝试博弈 ...

证券研究报告|行业研究报告 [Table_Date] 2026 年 2 月 3 日 [Table_Title] Kathleen Valley 矿山 2025Q4 锂精矿产销量分别环 比+21%、+45%至 10.5 万吨、11.2 万吨，已售锂 精矿的单位运营成本（FOB）环比下降 16%至 597 美元/吨 ►2025Q4 生产经营情况 1、产量 2025Q4，共生产了 105,342 吨锂精矿，环比增长 21%。 2、销量 2025Q4，共销售了 112,122 吨锂精矿，共计六个矿区，环 比增长 45%，平均品位为 5.1% Li₂ O。 3、平均实际成交价（CIF） 2025Q4，平均实际成交价（CIF）为 900 美元/吨（1,365 澳元/吨，折 SC6），反映了季度初适用的合同定价，而季度末 锂辉石价格尚未出现大幅上涨。 [Table_Title2] 有色金属-海外季报 [Table_Summary] 季报重点内容: 4、库存 季度末精矿库存为 13,800 吨，较上一季度有所减少，这反 映了强劲的销售业绩和客户需求。 5、单位运营成本 2025Q4，单位运营成本为 910 澳元/吨（597 ...

Investment Rating - The report recommends a "Buy" rating for the industry, predicting that the industry index will outperform the Shanghai Composite Index by 10% or more during the specified period [21]. Core Insights - The operational performance of Pilbara Minerals in Q4 2025 met expectations, reflecting ongoing improvements in mining efficiency and strategic initiatives aimed at maximizing ore processing capacity [1]. - The total mining volume increased from 7.7 million tons in the previous quarter to 8.1 million tons, indicating effective operational measures and a shift towards self-operated mining [1]. - The average expected actual selling price for lithium concentrate was $1,161 per ton (CIF, SC5.2), representing a 56% increase quarter-on-quarter and a 66% increase year-on-year [2]. - The company maintained a robust balance sheet with a cash balance of AUD 954 million and an undrawn credit facility of AUD 625 million as of December 31, 2025 [7]. Summary by Sections 1. Lithium Concentrate Production and Sales - In Q4 2025, lithium concentrate production totaled 208,000 tons, a 7% decrease quarter-on-quarter but an 11% increase year-on-year [2]. - Total sales of lithium concentrate reached 232,000 tons, an 8% increase quarter-on-quarter and a 14% increase year-on-year [2]. - The lithium recovery rate was 75.8%, and the company implemented additional crushing capacity to ensure operational continuity during periods of increased wear [2]. 2. Financial Performance - The company achieved revenue of AUD 373 million in Q4 2025, a 49% increase quarter-on-quarter and a 73% increase year-on-year [7]. - Operating cash profit was AUD 166 million, driven by price increases and ongoing cost optimization [7]. - Capital expenditures for Q4 2025 were AUD 45 million in cash terms, with a focus on mine development and infrastructure [8]. 3. Upstream Development Projects - The company is strategically positioning itself during the lithium market downturn to maintain operational capability and performance expectations [9]. - The Ngungaju processing plant is under evaluation for potential restart, with preparations including crusher upgrades [11]. - The P2000 feasibility study is ongoing, assessing the potential expansion of the Pilgangoora project to approximately 2 million tons per year [12]. 4. Chemical Business Strategy - The chemical business strategy focuses on maintaining long-term growth options within the lithium value chain [14]. - The midstream demonstration plant project in Australia was completed in Q4 2025, with updates on commissioning expected soon [16]. - The joint venture with POSCO for downstream production of lithium hydroxide is progressing, with production lines successfully meeting commercial standards [17].

Investment Rating - The report recommends a "Buy" rating for the industry, predicting that the industry index will outperform the Shanghai Composite Index by 10% or more during the specified period [22]. Core Insights - The operational performance of Pilbara Minerals in Q4 2025 met expectations, reflecting ongoing improvements in mining efficiency and strategic initiatives aimed at maximizing ore processing capacity [1]. - The total mining volume increased from 7.7 million tons in the previous quarter to 8.1 million tons, indicating effective operational measures and a shift towards a self-operated mining model [1]. - The average expected actual selling price for lithium concentrate was $1,161 per ton (CIF, SC5.2), representing a 56% increase quarter-on-quarter and a 66% increase year-on-year [2]. - The company maintained a robust balance sheet with a cash balance of AUD 954 million and an undrawn credit facility of AUD 625 million as of December 31, 2025 [7]. Summary by Sections 1. Lithium Concentrate Production and Sales - In Q4 2025, lithium concentrate production totaled 208,000 tons, a 7% decrease quarter-on-quarter but an 11% increase year-on-year [2]. - Total sales of lithium concentrate reached 232,000 tons, an 8% increase quarter-on-quarter and a 14% increase year-on-year [2]. - The lithium recovery rate for the quarter was 75.8%, despite increased ore processing [2]. 2. Financial Performance - The company achieved revenue of AUD 373 million in Q4 2025, a 49% increase quarter-on-quarter and a 73% increase year-on-year [7]. - Operating cash profit was AUD 166 million, driven by price increases and ongoing cost optimization [7]. - Capital expenditures for the quarter were AUD 45 million in cash terms, with a focus on mine development and infrastructure [8]. 3. Upstream Development Projects - The company is strategically positioning itself during the lithium market downturn to maintain operational capability and performance expectations [9]. - The Ngungaju processing plant is under evaluation for potential restart, with preparations ongoing for upgrades [11]. - The P2000 feasibility study is progressing, with results expected in Q1 2026, focusing on expanding production capacity [12]. 4. Chemical Business Strategy - The chemical business strategy emphasizes maintaining long-term growth options within the lithium value chain, including expanding downstream markets [14][15]. - The midstream demonstration plant project in Australia was completed in Q4 2025, with updates on commissioning expected soon [16]. - The joint venture with POSCO for downstream lithium hydroxide production continues to show technical strength, despite market challenges [17].

证券研究报告|行业研究报告 [Table_Date] 2026 年 2 月 3 日 [Table_Title] Kathleen Valley 矿山 2025Q4 锂精矿产销量分别环 比+21%、+45%至 10.5 万吨、11.2 万吨，已售锂 精矿的单位运营成本（FOB）环比下降 16%至 597 美元/吨 [Table_Title2] 有色金属-海外季报 [Table_Summary] 季报重点内容: ►2025Q4 生产经营情况 1、产量 2025Q4，共生产了 105,342 吨锂精矿，环比增长 21%。 2、销量 2025Q4，共销售了 112,122 吨锂精矿，共计六个矿区，环 比增长 45%，平均品位为 5.1% Li₂ O。 3、平均实际成交价（CIF） 2025Q4，平均实际成交价（CIF）为 900 美元/吨（1,365 澳元/吨，折 SC6），反映了季度初适用的合同定价，而季度末 锂辉石价格尚未出现大幅上涨。 4、库存 季度末精矿库存为 13,800 吨，较上一季度有所减少，这反 映了强劲的销售业绩和客户需求。 5、单位运营成本 2025Q4，单位运营成本为 910 澳元/吨（597 ...

证券研究报告|行业研究报告 [Table_Date] 2026 年 2 月 3 日 [Table_Title] MIN 2025Q4 锂精矿权益产量环比增长 1%至 13.8 万吨，权益锂精矿出货量环比增长 1%至 14.3 万吨 [Table_Title2] 有色金属-海外季报 [Table_Summary] 季报重点内容: ►锂矿 1）整体 本季度两处运营基地的锂辉石折 SC6 的总产量为 13.8 万 吨（16.6 万吨混合品位），折 SC6 的销量为 14.3 万吨（17.3 万吨混合品位）。 两处矿区本季度加权平均实际售价为 1094 美元/吨 （CIF，SC6），环比增长 29%。 MinRes 正在评估 Bald Hill 重启的各种方案和当前市场 状况，该设施于 2024 年 11 月进入维护保养状态。 2）MT MARION（100%基础） 2025Q4，由于 C3 矿坑最后平台开采期间天气潮湿，以及 N4 矿坑开工初期需要额外排水，导致矿石开采量减少，进料 总运输量环比下降 19%。N9 矿区仍然是主要开采矿石来源。 2026 财年矿石产量预期已上调至 19 万至 21 万吨（此前预 期为 ...

Investment Rating - The industry rating is recommended for investment [5] Core Insights - The small nucleic acid drug industry is positioned as a core track in precision medicine due to technological breakthroughs and differentiated treatments, focusing on ASO and siRNA types to regulate genes at the mRNA level, overcoming traditional "undruggable" targets and covering thousands of rare and chronic disease-related targets [2][11][12] - The global market for small nucleic acid drugs is rapidly expanding, with a projected growth from $2.7 billion in 2019 to $5.7 billion in 2024 (CAGR of 16.2%), and expected to reach $20.6 billion by 2029 (CAGR of 29.4%), driven by the increase in chronic diseases and significant breakthroughs in liver-targeted technologies [3][21] - The industry is characterized by a dual structure of "international leaders dominating + local companies breaking through," with companies like Alnylam and Ionis leading the market while local firms focus on niche areas [3][40] Summary by Sections Industry Overview - Small nucleic acid drugs leverage unique mechanisms to achieve precise gene regulation, offering advantages over traditional small molecules and antibody drugs [11][12] - The technology has evolved from being considered "undruggable" to providing viable treatment options for various diseases, including rare genetic disorders [12][13] Market Expansion - The market is transitioning from rare diseases to common diseases, with chronic disease treatments expected to dominate in the future [21][22] - The introduction of significant products like Novartis' Inclisiran is anticipated to drive sales growth, with a projected revenue of $750 million in 2024 [21][22] Competitive Landscape - International leaders like Alnylam have established a strong market presence with multiple commercialized products, while local companies are innovating in specific niches [40][41] - Alnylam's revenue reached $2.62 billion in the first three quarters of 2025, marking a significant milestone in profitability and cash flow [40][41]

证券研究报告|宏观点评报告 [Table_Date] 2026 年 02 月 02 日 [Table_Title] 资产配置日报：一"什"激千层浪 2 月 2 日，全球资产陷入混沌之中。1 月 30 日，特朗普正式提名凯文·沃什为下任美联储主席，市场随即开 启关于"美联储降息+缩表"的预期交易，当日美元指数快速拉升，美股指数普调，伦敦金现货价格大幅下跌。2 月 2 日，美联储换帅影响从欧美辐射至亚太市场，日经 225、韩国综指、恒生指数、MSCI越南分别下跌 1.25%、 5.26%、2.23%、2.46%，国内股市同样受到冲击，沪深 300、中证 2000、科创综指分别下跌 2.13%、2.41%、 3.95%。 权益市场缩量下跌。万得全 A下跌 2.71%，全天成交额 2.61 万亿元，较上周五（1 月 30 日）缩量 2558 亿 元。港股方面，恒生指数下跌 2.23%，恒生科技下跌 3.36%。南向资金净流入 19.07 亿港元，其中腾讯控股净流 入 13.04 亿港元，而华虹半导体和紫金矿业分别净流出 6.15 亿港元和 4.64 亿港元。 权益市场下跌，或是贵金属大跌的连锁反应。上周五黄金白银出现 ...

1. Report Industry Investment Rating There is no information provided in the content about the report's industry investment rating. 2. Core Viewpoints of the Report - In February, the bond market may continue to fluctuate, and the coupon strategy may remain a relatively prudent choice. With low credit spreads and the need to control duration risk, investment strategies can focus on the refined exploration of variety spreads, increasing the allocation of low - credit - risk and high - absolute - return varieties [1][2] - Secondary perpetual bonds still have investment value, but their volatility may increase. It is recommended that trading desks control their positions according to their liability - side conditions and try reverse operations [4][5] 3. Summary by Relevant Catalog 3.1 Credit Bonds: Explore Variety Spreads, Pay Attention to Volatility Risks of Secondary Perpetual Bonds 3.1.1 Low Credit Spreads, Focus on Variety Spread Exploration - In January, the long - end interest rate showed a trend of "rapid rise → rapid fall → slow fall", credit bond yields declined, and credit spreads narrowed across the board. Medium - and low - rated bonds outperformed high - rated ones, and medium - and long - term varieties performed better [10][11] - In February, the bond market may continue to fluctuate. For accounts with unstable liability sides, it is not recommended to chase long - term credit. Focusing on medium - and short - term varieties may be relatively advantageous. After the spread compression in January, credit spreads are generally at a low level [14][15] - Investment strategies can focus on three aspects: exploring the spreads of perpetual varieties, seizing the allocation opportunities of brokerage bonds and brokerage sub - bonds, and grasping the "oversold" repair opportunities of science and technology innovation bond component bonds [18] 3.1.2 Secondary Perpetual Bonds Still Have Allocation Value, but Volatility May Increase - In January 2026, bank secondary perpetual bonds had a catch - up rally, with yields declining across the board and credit spreads narrowing, generally outperforming ordinary credit bonds. This rally was mainly driven by funds, while insurance's net buying volume gradually decreased [32][33] - 3 - 5 - year large - bank secondary perpetual bonds still have certain allocation value for accounts with stable liability sides. However, with the rapid entry of trading - desk funds such as funds and the reduction of insurance's buying volume, the volatility of secondary perpetual bonds may increase [39] 3.2 Urban Investment Bonds: Net Financing Increased Year - on - Year, Medium - and Long - Term Transaction Activity Rose - In January, the net financing of urban investment bonds was positive and increased year - on - year. The issuance proportion of medium - and long - term urban investment bonds increased, and the weighted average issuance interest rate decreased across the board [42] - The yields of urban investment bonds declined across the board in January, with medium - and long - term and low - grade varieties performing better. The trading sentiment of urban investment bonds improved, and the medium - and long - term transaction activity increased [48][54] 3.3 Industrial Bonds: Short - End Issuance Proportion Increased, Medium - and Long - Term Secondary Performance was Superior - In January, the issuance and net financing scale of industrial bonds increased year - on - year. The short - term issuance proportion of industrial bonds continued to rise, and the issuance interest rate generally declined [57] - The yields of industrial bonds declined across the board in January, with medium - and long - term varieties showing obvious repair. Most industries' public offering bond yields declined, and medium - and long - term varieties performed better [59][62] 3.4 Bank Secondary Perpetual Bonds: Transaction Sentiment Warmed Up, Medium - and Long - Term Varieties Significantly Repaired - In January 2026, there were no new bank secondary perpetual bond issuances, and the net financing was - 415 billion yuan, a year - on - year decrease of 36.1 billion yuan [65] - The yields of bank secondary perpetual bonds declined across the board in January, with medium - and long - term varieties significantly repaired. The trading sentiment of bank secondary perpetual bonds warmed up, and the transaction of city commercial bank secondary perpetual bonds spread to medium - and low - grade bonds [71][74]